Skip to content

An open study for effectiveness of tipepidine hibenzate in ADHD children

An open study for effectiveness of tipepidine hibenzate in ADHD children - Asverin study for ADHD children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011695
Enrollment
20
Registered
2013-09-10
Start date
2013-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder (ADHD)

Interventions

Sponsors

University of Fukui, Research Center for Child Mental Development, Division of Psychosocial Support for Nurturing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Have a clinical diagnosis of ADHD confirmed according to DSM4 criteria. 2) Currently attending Fukui University hospital as an outpatient. 3) Must not be on medication, otherwise no oral intake of medication except for the following; methylphenidate, atomoxetine, atypical antipschotic medication( risperidone, olanzapine, aripiprazole, blonanserin, paliperidone). 4) Subjects within the age range of 6 to 17 years old. 5) No changes in medication for at least 4 weeks prior to baseline visit. 6) Must demonstrate an acceptable degree of compliance with medication and procedures in the opinion of the investigator.

Exclusion criteria

Exclusion criteria: 1) Hypersensitivity towards tipepidine hibenzate. 2) Subjects who have not yet received informed consent of the current diagnosis. 3) Subjects who have any other current DSM4 diagnosis of the following; "Pervasive development disorder", "Schizophrenia and Other Psychotic Disorders","Delirium, Dementia, and Amnestic and Other Cognitive Disorders", "Substance-Related Disorders(exemption of Caffeine related and nicotine related disorders)","mood disorders","eating disorders","personality disorders". 4) Subjects who have a physical disorder with a need of strict diet, or a diagnosis of a severe physical disorder. 5) Subjects who are receiving medication other than the above mentioned. 6) Women who are breastfeeding, pregnant, possibility of pregnancy, or have a wish of early pregnancy. 7) Subjects who have participated in other clinical studies 3 months prior to this study. 8) Subjects who are planned for an immediate therapeutic plan change due to unstable physical or psychological symptoms. 9) Subjects who have a history of suicide attempt within the past 1 year. 10) Subjects who, in the Investigator's opinion, might not be suitable for the study.

Design outcomes

Primary

MeasureTime frame
ADHD-RS Clincal global impression DN-CAS

Countries

Japan

Contacts

Public ContactAkemi Tomoda

University of Fukui, Research Center for Child Mental Development Division of Psychosocial Support for Nurturing

atomoda@u-fukui.ac.jp0776-61-8677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026